![]() ![]() Conclusion: GRACE risk score demonstrates better predictive accuracy than TIMI risk score for in-hospital mortality in NSTEMI patients in this patient cohort. The prescription percentage of statins, β-blocker, angiotensin converting enzyme inhibitors or angiotensin Ⅱ receptor blockers, and aldosterone antagonists were 94.8% ( n=5 587), 71.7% ( n=4 228), 65.5% ( n=3 864) and 26.0% ( n=1 533) respectively. Six hundreds and forty five patients (10.9%) received primary percutaneous coronary intervention, and 6 patients underwent emergent coronary artery bypass grafting surgery (0.1%), and the median time of reperfusion was 529.5 (256.0, 1 065.0) minutes. Pre-procedural TIMI flow is significantly related to 1-year mortality in high-risk patients, compared to low-risk patients (16.3 and 3.8 respectively). in a population of 1791 patients with STE-ACS, divided into high and low risk based on the TIMI risk score. The incidence of pre-hospital cardiac arrest was 3.6% ( n=213) among 5 896 NSTEMI patients. Similar results were presented by De Luca et al. The in-hospital mortality was 6.0% ( n=353) and the median length of hospital stay was 10.0 (7.0, 13.0) days. Some form of in- patient risk assessment (i.e. Results: Among 5 896 NSTEMI patients (age was (65.4☑2.1) years old), 68.2% ( n=4 020) were males. Conclusions: Patients with NSTEMI and low TIMI score can safely be risk stratified with an ETT. Their prognostic value was evaluated by the endpoint of in-hospital mortality. For each patient, TIMI and GRACE risk scores were calculated using specific variables collected at admission. From January 2013 to September 2014, 5 896 consecutive non-ST-segment elevation myocardial infarction patients who were admitted to 107 hospitals within 7 days of symptom onset were enrolled. Among 31 provinces, municipalities or autonomous districts in China, at least one tertiary and secondary hospital was selected. Methods: Data of present study derived from the prospective, multi-center registry trial of Chinese AMI (CAMI). Objective: To evaluate the prognostic value of the thrombolysis in myocardial infarction (TIMI) and global registry of acute coronary events (GRACE) risk scores for in-hospital mortality in Chinese non-ST-segment elevation myocardial infarction (NSTEMI) patients. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |